Nicole S. Jones, a top executive at Cigna, sold $1.51 million worth of company shares on March 3, 2025. The transaction was ...
ARS Pharmaceuticals (SPRY) announced that the FDA has approved neffy 1 mg for the treatment of Type I Allergic Reactions, including ...
Envision’s board appointments include Fredrik Eliasson as Chair of the Board of Directors and Christopher Bradbury as Board Director.